Effect of ex vivo-expanded γσ-T cells combined with galectin-1 antibody on the growth of human cervical cancer xenografts in SCID mice

Clinical and Investigative Medicine

Volumn 33, Issue 5, 2010, Pages

  Li, Hua ^a   Wang, Yubin ^b   Zhou, Fuxiang ^a  

^a WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GALECTIN 1; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL; ARTICLE; DRUG SCREENING; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METHODOLOGY; MOUSE; MOUSE MUTANT; T LYMPHOCYTE; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

ANIMALS; ANTIBODIES; CELL LINE, TUMOR; FEMALE; GALECTIN 1; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, SCID; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES; UTERINE CERVICAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77957886732     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Girardi M. Immunosurveillance and immunoregulation by gammadelta T cells. J Invest Dermatol. 2006. 126(1): 25-31.
2. Girardi M, Hayday AC. Immunosurveillance by gam-madelta T cells: focus on the murine system. Chem Immunol Allergy. 2005. 86: 136-50.
3. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci USA. 1999. 96(12): 6879-84.
4. Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science. 1998. 279(5357): 1737-40.
5. Kabelitz D, Wesch D, He W. Perspectives of gam-madelta T cells in tumor immunology. Cancer Res. 2007. 67(1): 5-8.
6. Cerwenka A, Bakker AB, McClanahan T, et al. Reti-noic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity. 2000. 12(6): 721-7.
7. Maeurer MJ, Martin D, Walter W, et al. Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin. J Exp Med. 1996. 183(4): 1681-96.
8. Kowalczyk D, Skorupski W, Drews M, Nowak J. Different pattern of T cell receptor delta gene rearrangement in tumour-infiltrating lymphocytes and peripheral blood in patients with solid tumours. Cancer Immunol Immunother. 1994. 39(4): 275-8.
9. Ferrarini M, Heltai S, Chiesa G, Sabbadini MG. V delta 1+ gamma/delta T lymphocytes infiltrating human lung cancer express the CD8 alpha/alpha homo-dimer. Scand J Immunol. 1994. 40(3): 363-7.
10. Kumamaru W, Nakamura S, Kadena T, et al. T-cell receptor Vbeta gene usage by T cells reactive with the tumor-rejection antigen SART-1 in oral squamous cell carcinoma. Int J Cancer. 2004. 108(5): 686-95.
11. Kitayama J, Atomi Y, Nagawa H, et al. Functional analysis of TCR gamma delta+ T cells in tumour-infiltrating lymphocytes (TIL) of human pancreatic cancer. Clin Exp Immunol. 1993. 93(3): 442-7.
12. Camby I, Le MM, Lefranc F, Kiss R. Galectin-1: a small protein with major functions. Glycobiology. 2006. 16(11): 137R-157R.
13. Le MM, Lefranc F, Mijatovic T, et al. Evidence of galectin-1 involvement in glioma chemoresistance. Toxicol Appl Pharmacol. 2008. 229(2): 172-83.
14. Le MM, Fortin S, Mathieu V, Kiss R, Lefranc F. Galectins and gliomas. Brain Pathol. 2010. 20(1): 17-27.
15. Camby I, Le MM, Mathieu V, Ingrassia L, Lefranc F, Kiss R. Galectin-1 as a potential therapeutic target for cancer progression.Drugs Fut.2008.33(12): 1057-63.
16. Kovacs-Solyom F, Blasko A, Fajka-Boja R, et al. Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1. Immunol Lett. 2009.
17. Rabinovich GA. Galectin-1 as a potential cancer target. Br J Cancer. 2005. 92(7): 1188-92.
18. Kohrenhagen N, Volker HU, Kapp M, Dietl J, Kam-merer U. Increased expression of galectin-1 during the progression of cervical neoplasia. Int J Gynecol Cancer. 2006. 16(6): 2018-22.
19. Lozupone F, Luciani F, Venditti M, et al. Murine granulocytes control human tumor growth in SCID mice. Int J Cancer. 2000. 87(4): 569-73.
20. Yu S, He W, Chen J, Zhang F, Ba D. Expansion and immunological study of human tumor infiltrating gamma/delta T lymphocytes in vitro. Int Arch Allergy Immunol. 1999. 119(1): 31-7.
21. Winn HJ. Immune mechanisms in homotransplanta-tion. II. Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homografts. J Immunol. 1961. 86: 228-39.
22. Rizza P, Santini SM, Logozzi MA, et al. T-cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitu-tion: in vivo effects of HIV on highly activated human immune cells. J Virol. 1996. 70(11): 7958-64.
23. Chen J, Niu H, He W, Ba D. Antitumor activity of expanded human tumor-infiltrating gammadelta T lymphocytes. Int Arch Allergy Immunol. 2001. 125(3): 256-63.
24. Vyakarnam A, Lenneman AJ, Lakkides KM, Patterson RJ, Wang JL. A comparative nuclear localization study of galectin-1 with other splicing components. Exp Cell Res. 1998. 242(2): 419-28.
25. Achour M, Kahla S, Zeghal D, et al. Analysis of antibody response to HPV 16 and HPV 18 antigens in Tunisian patients. Viral Immunol. 2009. 22(1): 7-16.
26. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006. 56(2): 106-30.
27. Martinet L, Poupot R, Fournie JJ. Pitfalls on the road-map to gammadelta T cell-based cancer immunothera-pies. Immunol Lett. 2009. 124(1): 1-8.
28. Demotte N, Stroobant V, Courtoy PJ, et al. Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes. Immunity. 2008. 28(3): 414-24.
29. Lee JW, Song SY, Choi JJ, et al. Decreased galectin-3 expression during the progression of cervical neopla-sia. J Cancer Res Clin Oncol. 2006. 132(4): 241-7.
30. Dhirapong A, Lleo A, Leung P, Gershwin ME, Liu FT. The immunological potential of galectin-1 and-3. Autoimmun Rev. 2009. 8(5): 360-3.
31. Yamaoka K, Mishima K, Nagashima Y, Asai A, Sanai Y, Kirino T. Expression of galectin-1 mRNA correlates with the malignant potential of human gliomas and expression of antisense galectin-1 inhibits the growth of 9 glioma cells. J Neurosci Res. 2000. 59(6): 722-30.